{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,3]],"date-time":"2025-08-03T04:18:37Z","timestamp":1754194717239},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s12664-016-0645-0","type":"journal-article","created":{"date-parts":[[2016,4,8]],"date-time":"2016-04-08T18:39:10Z","timestamp":1460140750000},"page":"117-122","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proton pump inhibitors and other disease-based factors in the recurrence of adverse cardiovascular events following percutaneous coronary angiography: A long-term cohort"],"prefix":"10.1007","volume":"35","author":[{"given":"Adil","family":"Ayub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Om","family":"Parkash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Buria","family":"Naeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duraiz","family":"Murtaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir Hameed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wasim","family":"Jafri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeed","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,8]]},"reference":[{"key":"645_CR1","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1161\/CIR.0b013e31823ba622","volume":"124","author":"GN Levine","year":"2011","unstructured":"Levine GN, Bates ER, Blankenship JC, et al. ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124:e574\u2013651.","journal-title":"Circulation"},{"key":"645_CR2","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.jacc.2008.08.002","volume":"52","author":"DL Bhatt","year":"2008","unstructured":"Bhatt DL, Scheiman J, Abraham NS, et al. ACCF\/ACG\/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008;52:1502\u201317.","journal-title":"J Am Coll Cardiol"},{"key":"645_CR3","doi-asserted-by":"crossref","unstructured":"Siller-Matula JM, Spiel AO, Lang IM, Kreiner G, Christ G, Jilma B. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J. 2009;157:148.e1\u20135.","DOI":"10.1016\/j.ahj.2008.09.017"},{"key":"645_CR4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1365-2125.2010.03717.x","volume":"70","author":"T Furuta","year":"2010","unstructured":"Furuta T, Iwaki T, Umemura K. Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. Br J Clin Pharmacol. 2010;70:383\u201392.","journal-title":"Br J Clin Pharmacol"},{"key":"645_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/clpt.2013.105","volume":"94","author":"SA Scott","year":"2013","unstructured":"Scott SA, Sangkuhl K, Stein CM, et al. Clinical pharmacogenetics implementation consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther. 2013;94:317\u201323.","journal-title":"Clin Pharmacol Ther"},{"key":"645_CR6","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jacc.2007.06.064","volume":"51","author":"M Gilard","year":"2008","unstructured":"Gilard M, Arnaud B, Cornily JC, et al. Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study. J Am Coll Cardiol. 2008;51:256\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"645_CR7","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.thromres.2009.08.016","volume":"125","author":"CS Zuern","year":"2010","unstructured":"Zuern CS, Geisler T, Lutilsky N, Winter S, Schwab M, Gawaz M. Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy. Thromb Res. 2010;125:e51\u20134.","journal-title":"Thromb Res"},{"key":"645_CR8","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1503\/cmaj.082001","volume":"180","author":"DN Juurlink","year":"2009","unstructured":"Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ. 2009;180:713\u20138.","journal-title":"CMAJ"},{"key":"645_CR9","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCULATIONAHA.110.965640","volume":"123","author":"T Simon","year":"2011","unstructured":"Simon T, Steg PG, Gilard M, et al. Clinical events as a function of proton pump inhibitor use, clopidogrel use, and cytochrome P450 2C19 genotype in a large nationwide cohort of acute myocardial infarction: results from the French Registry of Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) registry. Circulation. 2011;123:474\u201382.","journal-title":"Circulation"},{"key":"645_CR10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","volume":"363","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Cryer BL, Contant CF, et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010;363:1909\u201317.","journal-title":"N Engl J Med"},{"key":"645_CR11","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1053\/j.gastro.2010.11.056","volume":"140","author":"PI Hsu","year":"2011","unstructured":"Hsu PI, Lai KH, Liu CP. Esomeprazole with clopidogrel reduces peptic ulcer recurrence, compared with clopidogrel alone, in patients with atherosclerosis. Gastroenterology. 2011;140:791\u20138.","journal-title":"Gastroenterology"},{"key":"645_CR12","doi-asserted-by":"crossref","first-page":"e000248","DOI":"10.1136\/openhrt-2015-000248","volume":"2","author":"RN Cardoso","year":"2015","unstructured":"Cardoso RN, Benjo AM, DiNicolantonio JJ, et al. Incidence of cardiovascular events and gastrointestinal bleeding in patients receiving clopidogrel with and without proton pump inhibitors: an updated meta-analysis. Open Heart. 2015;2:e000248.","journal-title":"Open Heart"},{"key":"645_CR13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijcard.2012.03.085","volume":"167","author":"CS Kwok","year":"2013","unstructured":"Kwok CS, Jeevanantham V, Dawn B, Loke YK. No consistent evidence of differential cardiovascular risk amongst proton-pump inhibitors when used with clopidogrel: meta-analysis. Int J Cardiol. 2013;167:965\u201374.","journal-title":"Int J Cardiol"},{"key":"645_CR14","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1365-2036.2010.04247.x","volume":"31","author":"CS Kwok","year":"2010","unstructured":"Kwok CS, Loke YK. Meta-analysis: the effects of proton pump inhibitors on cardiovascular events and mortality in patients receiving clopidogrel. Aliment Pharmacol Ther. 2010;31:810\u201323.","journal-title":"Aliment Pharmacol Ther"},{"key":"645_CR15","unstructured":"Implementation of the International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). Epidemiol Bull. 1997; 18:1\u20134."},{"key":"645_CR16","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11886-014-0492-5","volume":"16","author":"H White","year":"2014","unstructured":"White H, Thygesen K, Alpert JS, Jaffe A. Universal MI definition update for cardiovascular disease. Curr Cardiol Rep. 2014;16:492.","journal-title":"Curr Cardiol Rep"},{"issue":"Suppl C","key":"645_CR17","first-page":"C39","volume":"4","author":"P Vranckx","year":"2008","unstructured":"Vranckx P, Kint PP, Morel MA, Van Es GA, Serruys PW, Cutlip DE. Identifying stent thrombosis, a critical appraisal of the academic research consortium (ARC) consensus definitions: a lighthouse and as a toe in the water. EuroIntervention. 2008;4 Suppl C:C39\u201344.","journal-title":"EuroIntervention"},{"key":"645_CR18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1007\/s10620-011-2007-1","volume":"57","author":"LB Gerson","year":"2012","unstructured":"Gerson LB, McMahon D, Olkin I, Stave C, Rockson SG. Lack of significant interactions between clopidogrel and proton pump inhibitor therapy: meta-analysis of existing literature. Dig Dis Sci. 2012;57:1304\u201313.","journal-title":"Dig Dis Sci"},{"key":"645_CR19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/j.1875-9114.2012.01112.x","volume":"32","author":"SM Bhurke","year":"2012","unstructured":"Bhurke SM, Martin BC, Li C, Franks AM, Bursac Z, Said Q. Effect of the clopidogrel-proton pump inhibitor drug interaction on adverse cardiovascular events in patients with acute coronary syndrome. Pharmacotherapy. 2012;32:809\u201318.","journal-title":"Pharmacotherapy"},{"key":"645_CR20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.thromres.2014.01.003","volume":"133","author":"S Hokimoto","year":"2014","unstructured":"Hokimoto S, Mizobe M, Akasaka T, et al. Impact of CYP2C19 polymorphism and proton pump inhibitors on platelet reactivity to clopidogrel and clinical outcomes following stent implantation. Thromb Res. 2014;133:599\u2013605.","journal-title":"Thromb Res"},{"key":"645_CR21","first-page":"205","volume":"76","author":"GG Ching","year":"2012","unstructured":"Ching GG, Li D, Baker WL, et al. Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors. Conn Med. 2012;76:205\u201311.","journal-title":"Conn Med"},{"key":"645_CR22","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.111.032912","volume":"125","author":"SG Goodman","year":"2012","unstructured":"Goodman SG, Clare R, Pieper KS, et al. Association of proton pump inhibitor use on cardiovascular outcomes with clopidogrel and ticagrelor: insights from the platelet inhibition and patient outcomes trial. Circulation. 2012;125:978\u201386.","journal-title":"Circulation"},{"key":"645_CR23","doi-asserted-by":"crossref","first-page":"d2690","DOI":"10.1136\/bmj.d2690","volume":"342","author":"M Charlot","year":"2011","unstructured":"Charlot M, Grove EL, Hansen PR, et al. Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. BMJ. 2011;342:d2690.","journal-title":"BMJ"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0645-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12664-016-0645-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-016-0645-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:43:58Z","timestamp":1718466238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12664-016-0645-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s12664-016-0645-0","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}